AYTU BIOPHARMA, INC Sales Revenue, Services, Net (Deprecated 2018-01-31)
AYTU BIOPHARMA, INC (AYTU) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $1.00 thousand for the 3-month period ending 2014-05-31, per its 10-Q filed 2014-07-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2014-11-26
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-05-31 was $1.00K, a 42.86% decline year-over-year.
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2014-02-28 was $0.00.
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2013-11-30 was $0.00.
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2013-08-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2013 was $1.75K, a 0.00% change from fiscal 2012.
- AYTU BIOPHARMA, INC sales revenue, services, net (deprecated 2018-01-31) for fiscal 2012 was $1.75K.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 81 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 84 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 87 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 90 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 93 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 96 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 99 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 102 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 105 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 108 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-05-31 | $1.00K 10-Q · filed 2014-07-10 | $1.00K derived: sum of 2 quarters · filed 2014-07-10 | $1.00K 10-Q · filed 2014-07-10 | $1.00K derived: sum of 4 quarters · filed 2014-11-26 | $6.25K 10-Q · filed 2014-07-10 | ||||||||||
| 2014-02-28 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $1.75K derived: sum of 4 quarters · filed 2014-11-26 | $5.25K 10-Q · filed 2014-04-11 | ||||||||||
| 2013-11-30 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2014-01-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $1.75K derived: sum of 3 quarters · filed 2014-11-26 | $1.75K derived: sum of 4 quarters · filed 2014-11-26 | $5.25K 10-Q · filed 2014-01-10 | ||||||||||
| 2013-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $1.75K derived: sum of 2 quarters · filed 2014-11-26 | $1.75K derived: sum of 3 quarters · filed 2014-11-26 | $1.75K 10-K · filed 2014-11-26 | $5.25K 10-K · filed 2014-11-26 | ||||||||||
| 2013-05-31 | $1.75K 10-Q · filed 2014-07-10 | $1.75K derived: sum of 2 quarters · filed 2013-06-28 | $1.75K 10-Q · filed 2014-07-10 | $3.50K derived: sum of 4 quarters · filed 2013-06-28 | $5.25K 10-Q · filed 2013-06-28 | ||||||||||
| 2013-02-28 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-04-15 | $0.00 derived: sum of 2 quarters · filed 2013-04-15 | $1.75K derived: sum of 3 quarters · filed 2013-04-15 | $1.75K derived: sum of 4 quarters · filed 2013-04-15 | $3.50K 10-Q · filed 2013-04-15 | ||||||||||
| 2012-11-30 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2013-01-14 | $1.75K derived: sum of 2 quarters · filed 2013-01-14 | $1.75K derived: sum of 3 quarters · filed 2013-01-14 | $1.75K derived: sum of 4 quarters · filed 2013-01-14 | $3.50K 10-Q · filed 2013-01-14 | ||||||||||
| 2012-08-31 | $1.75K derived: 10-K 90 month − 10-Q 87 month · filed 2012-11-29 | $1.75K derived: sum of 2 quarters · filed 2012-11-29 | $1.75K derived: sum of 3 quarters · filed 2012-11-29 | $1.75K 10-K · filed 2014-11-26 | $3.50K 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | $0.00 derived: 10-Q 87 month − 10-Q 84 month · filed 2012-06-26 | $0.00 derived: sum of 2 quarters · filed 2012-06-26 | $0.00 derived: sum of 3 quarters · filed 2012-06-26 | $1.75K 10-Q · filed 2012-06-26 | |||||||||||
| 2012-02-29 | $0.00 derived: 10-Q 84 month − 10-Q 81 month · filed 2012-04-12 | $0.00 derived: sum of 2 quarters · filed 2012-04-12 | $1.75K 10-Q · filed 2012-04-12 | ||||||||||||
| 2011-11-30 | $0.00 10-Q · filed 2011-12-23 | $1.75K 10-Q · filed 2011-12-23 | |||||||||||||
| 2010-11-30 | $0.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |